FIELD: medicine.
SUBSTANCE: invention refers to medical products and concerns a pharmaceutical composition containing 2,4-dichlorbenzyl alcohol combined with amylmethacresol and used for treatment or prevention of viral infections caused by SARS coronaviruses. The pharmaceutical composition is presented in the liquid acidulous oral form, or acidified sucking or chewing solid dosage form. There is also disclosed application of 2,4-dihclorbenzyl alcohol and amylmethacresol for making a medicinal agent for treatment or prevention of viral infections caused by SARS coronaviruses.
EFFECT: invention aims at development of the agent for treatment of viral infections caused by SARS coronaviruses with Urbani phenotype.
9 cl, 9 tbl, 27 ex
